Harvard researchers have joined with counterparts in the U.S. and Botswana governments to conduct a major evaluation of AIDS treatment targeted specifically to reduce infectivity.
AIDS researchers gathered at the Harvard School of Public Health to mark 10 years of work under a landmark federal anti-AIDS program that has led to significant progress against the epidemic.
A new rapid test for tuberculosis (TB) could substantially and cost-effectively reduce TB deaths and improve treatment in southern Africa — a region where both HIV and tuberculosis are common — according to a new study by Harvard School of Public Health researchers
A new four-year, $20 million grant from the U.S. Centers for Disease Control and Prevention (CDC) will enable Harvard School of Public Health (HSPH) researchers to evaluate the impact and cost-effectiveness of a unique combination of HIV prevention strategies in Botswana.
Though there are signs that the Botswana AIDS epidemic is slowing, the disease remains the top cause of death in the southern African nation. HIV infection rates are down nationwide to 24 percent, while life expectancy, which had fallen from 64 in 1990 to 40, rose to 50 in 1997.
The Michael C. Rockefeller Memorial Fellowships Administrative Board has awarded fellowships to six graduating seniors.
A Harvard School of Public Health AIDS Initiative trial that gave HIV-positive mothers in Botswana antiretroviral drugs during the months after birth showed a dramatic reduction in the transmission of the virus from mothers to breast-fed babies.
Max Essex, the Mary Woodard Lasker Professor of Health Sciences, and Unity Dow track the Botswana HIV/AIDS crisis through heartrending narratives of those affected by the disease — an estimated one out of four adults.
Harvard Africa Focus opens series of panels, lectures, and performances highlighting the continent’s life and culture.
Harvard senior Samuel Bjork has won a prestigious Marshall Scholarship, allowing him to study for two years in the United Kingdom at the university of his choice.
Harvard President Drew Faust saw firsthand how Harvard is helping the African nation of Botswana to fight AIDS, when she toured facilities in two communities where a Harvard-Botswana partnership is operating anti-AIDS programs.
Esther Mwaikambo is used to starting small. Until her teaching hospital was started in 1997, there was only one medical school in Tanzania, graduating 25 to 40 doctors annually.
Harvard President Drew Faust hosts students from African countries to solicit their input and advice in advance of her November trip to South Africa and Botswana.
An African leader whose anti-AIDS programs resulted in one of the continent’s few HIV success stories said Monday (April 13) that he is shifting his efforts from treatment toward prevention in hopes of creating an “HIV-free” generation.
While her classmates in Cambridge were shivering through a New England February, Sandy Bolm was sweltering in the heat of a Botswana summer, staring her future in the face in the labs of the Botswana-Harvard Partnership.
Ampheletse Medupe’s headaches just wouldn’t go away. Living in her small, neat home outside the African nation of Botswana’s capital, the mother of four kept on as best she could until sores broke out on her face.
The man and woman grin down from the large billboard overlooking the road to the hospital in Mochudi, a small town outside Botswana’s capital of Gaborone.